Janssen gets FDA approval for new Darzalex combination
The US Food and Drug Administration has approved yet another combination treatment for bone marrow cancer involving Darzalex – this time, in combination with two other drugs.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
Darzalex Faspro has been approved by the FDA in combination with pomalidomide and dexamethasone.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA changes prescribing information for new Alzheimer's drug
For subscribers
.jpg&w=384&q=75)
